| CD274 |
Q9NZQ7
|
CD274 molecule
|
Receptor
|
1.9E-02 |
0.324 |
0.923 |
| ERBB2 |
P04626
|
erb-b2 receptor tyrosine kinase 2
|
Kinase
|
6.0E-03 |
0.328 |
0.923 |
| MTOR |
P42345
|
mechanistic target of rapamycin kinase
|
Kinase
|
1.00 |
0.343 |
0.885 |
| IL2 |
P60568
|
interleukin 2
|
|
0.48 |
0.336 |
0.885 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
| MYC |
P01106
|
MYC proto-oncogene, bHLH transcription factor
|
Transcription factor
|
1.00 |
0.344 |
0.923 |
| CASP3 |
P42574
|
caspase 3
|
Enzyme
|
0.10 |
0.351 |
0.923 |
| TP63 |
Q9H3D4
|
tumor protein p63
|
Transcription factor
|
1.00 |
0.362 |
0.769 |
| CAT |
P04040
|
catalase
|
Enzyme
|
1.6E-10 |
0.359 |
0.962 |
| CXCR4 |
P61073
|
C-X-C motif chemokine receptor 4
|
G-protein coupled receptor
|
1.8E-02 |
0.362 |
0.923 |
| ICAM1 |
P05362
|
intercellular adhesion molecule 1
|
|
3.5E-02 |
0.364 |
0.962 |
| HMGB1 |
P09429
|
high mobility group box 1
|
Nucleic acid binding
|
0.82 |
0.368 |
0.923 |
| CTLA4 |
P16410
|
cytotoxic T-lymphocyte associated protein 4
|
|
0.94 |
0.369 |
0.923 |
| KIT |
P10721
|
KIT proto-oncogene, receptor tyrosine kinase
|
Kinase
|
0.98 |
0.366 |
0.808 |
| CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
| MTCO2P12 |
|
MT-CO2 pseudogene 12
|
|
|
0.368 |
0.962 |
| HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
| FOXP3 |
Q9BZS1
|
forkhead box P3
|
|
0.99 |
0.368 |
0.846 |
| ATM |
Q13315
|
ATM serine/threonine kinase
|
Kinase
|
5.6E-47 |
0.374 |
0.885 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| HGF |
P14210
|
hepatocyte growth factor
|
Enzyme
|
1.00 |
0.374 |
0.885 |
| MAPK3 |
P27361
|
mitogen-activated protein kinase 3
|
Kinase
|
3.7E-02 |
0.379 |
0.885 |
| EPO |
P01588
|
erythropoietin
|
|
1.1E-02 |
0.381 |
0.885 |
| JAK2 |
O60674
|
Janus kinase 2
|
Kinase
|
0.65 |
0.385 |
0.885 |